A federal judge green-lights a shareholders lawsuit over its Infuse bone-growth protein that accuses Medtronic and its management, including former CEO William Hawkins, of misleading investors about Infuse's safety risks and commercial upside.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sRw61z
Cap comentari:
Publica un comentari a l'entrada